Arabic Arabic English English French French German German
dark

Developing & Validating Commonly Employed Particle Sizing Methods to Support BE and Product Quality

Xiaoming Xu from the Office of Pharmaceutical Quality discusses common issues and considerations in the development and validation of an analytical method for particle size characterization.

Learn more at https://www.fda.gov/drugs/regulatory-education-industry-advancing-innovative-science-generic-drug-development-workshop 
_______________________________ 
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  

Upcoming Training – https://www.fda.gov/cdersbia   
SBIA Listserv – https://public.govdelivery.com/accounts/USFDA/subscriber/new?topic_id=USFDA_352
SBIA 2020 Playlist – https://www.youtube.com/playlist?list=PLey4Qe-UxcxZiTopt4biuIyxmUQJDkaWb  
SBIA LinkedIn – https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance  
SBIA Training Resources – https://www.fda.gov/cderbsbialearn  
Twitter – https://twitter.com/FDA_Drug_Info  
Email – CDERSBIA@fda.hhs.gov  
Phone – (301) 796-6707 I (866) 405-5367

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

MoHAP joins HCFL alliance to promote AI and innovation in healthcare

Next Post

2 new cases of COVID-19 in managed isolation

Related Posts
Total
0
Share